Pharmaceutical News

RSS

New flu drug Xofluza approved - FDA emphasizes importance of flu shots

A new drug that works against flu has been developed and has been approved by the Food and Drug Administration (FDA) yesterday (24th October 2018). Until now the only drug available for flu is oseltamivir (Tamiflu) which is to be administered by two pills per day for five days after symptoms appear.

25 Oct 2018

Effective dose of cannabidiol for safe pain relief without the typical 'high'

In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Center and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol for safe pain relief without the typical "high" or euphoria produced by the THC.

25 Oct 2018

Research shows link between higher generic drug use and Medicare Part D star ratings

Value in Health, the official journal of ISPOR, announced today the publication of new research showing that Medicare Part D prescription plans with higher generic drug use have higher summary star ratings and improved member experience.

25 Oct 2018

FDA approves new antiviral flu treatment

Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.

24 Oct 2018

Federal court orders Tennessee-based company to stop selling OTC drug products

A federal court ordered a Tennessee-based company to stop selling over-the-counter (OTC) drug products until the company complies with the Federal Food, Drug, and Cosmetic Act and other requirements listed in a consent decree.

24 Oct 2018

Researchers uncover new lead for mechanism of action of frontline Type 2 diabetes drug

Canadian and British researchers have discovered how the frontline Type 2 diabetes drug metformin may work to help cells better take up and use glucose.

24 Oct 2018

FDA targets 465 websites that sell potentially dangerous, unapproved drugs

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, acted this week to target 465 websites that illegally sell potentially dangerous, unapproved versions of opioid, oncology and antiviral prescription drugs to U.S. consumers.

23 Oct 2018

Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics

The trillions of bacteria in the human gut affect our health in multiple ways including effects on immune functions and metabolism.

23 Oct 2018

Study uncovers new mechanism of action in a first-line drug for diabetes

For decades, metformin has been the first-line drug in the treatment of type 2 diabetes, lowering blood glucose levels by inhibiting glucose production in the liver. Metformin also improves glucose uptake and use by muscle tissue.

23 Oct 2018

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Treatment with the cyclin dependent kinase 4/6 inhibitor palbociclib achieves a clinically meaningful improvement in overall survival in patients with hormone receptor positive human epidermal growth factor receptor-2 negative advanced breast cancer that has relapsed or progressed on hormonal therapy, according to the final analysis of overall survival results from the PALOMA-3 study reported at ESMO 2018.

23 Oct 2018

Drugs approved for breast cancer treatment are effective and well tolerated in men

There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in men with breast cancer and two further studies to be reported at ESMO 2018.

23 Oct 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

Study: 12% of frequent marijuana smokers experience cannabis withdrawal syndrome

As the number of Americans who regularly use cannabis has climbed, so too has the number of those experiencing cannabis withdrawal symptoms.

23 Oct 2018

Drug cocktail that increases lifespan discovered

A team of researchers led by Principal Investigator Dr Jan Gruber from Yale-NUS College has discovered a combination of pharmaceutical drugs that not only increases healthy lifespan in the microscopic worm Caenorhabditis elegans (C. elegans), but also delays the rate of ageing in them, a finding that could someday mean longer, healthier lives for humans.

22 Oct 2018

Aspirin may be effective in preventing blood clots after knee replacement

When it comes to preventing blood clots after a knee replacement, good old aspirin may be just as effective as newer, more expensive drugs.

22 Oct 2018

Educational initiatives needed to improve knowledge about biosimilars in oncology

Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines - but they are also expensive.

22 Oct 2018

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Genentech, a member of the Roche Group, announced today that the U.S. Food and Drug Administration has approved an update to the Rituxan® (rituximab) label to include information on follow up treatment of adult patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis who have achieved disease control with induction treatment.

22 Oct 2018

Pharmaceutical News

New flu drug Xofluza approved - FDA emphasizes importance of flu shots

Effective dose of cannabidiol for safe pain relief without the typical 'high'

Research shows link between higher generic drug use and Medicare Part D star ratings

FDA approves new antiviral flu treatment

Federal court orders Tennessee-based company to stop selling OTC drug products

Researchers uncover new lead for mechanism of action of frontline Type 2 diabetes drug

FDA targets 465 websites that sell potentially dangerous, unapproved drugs

Gut bacterial community of healthy adults recovers after short-term exposure to broad-spectrum antibiotics

Study uncovers new mechanism of action in a first-line drug for diabetes

Study reveals new treatment option for women with advanced breast cancer resistant to hormone therapy

Drugs approved for breast cancer treatment are effective and well tolerated in men

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Study: 12% of frequent marijuana smokers experience cannabis withdrawal syndrome

Drug cocktail that increases lifespan discovered

Aspirin may be effective in preventing blood clots after knee replacement

Educational initiatives needed to improve knowledge about biosimilars in oncology

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

Immunotherapy medicine found to be effective in treating uveitis

Study: Some countries take more time for reimbursement decisions on new cancer drugs

Could we prevent Alzheimer's disease by treating herpes?

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News